<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-title>BMC Microbiology</journal-title><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2180-7-69</article-id><article-id pub-id-type="pmid">17645809</article-id><article-id pub-id-type="doi">10.1186/1471-2180-7-69</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Involvement of the YneS/YgiH and PlsX proteins in phospholipid biosynthesis in both <italic>Bacillus subtilis </italic>and <italic>Escherichia coli</italic></article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Yoshimura</surname><given-names>Mika</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>y-mika@is.naist.jp</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Oshima</surname><given-names>Taku</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>taku@bs.naist.jp</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Ogasawara</surname><given-names>Naotake</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>nogasawa@bs.naist.jp</email></contrib></contrib-group><aff id="I1"><label>1</label>Graduate School of Information Science, Nara Institute of Science and Technology, Ikoma, Nara 630-0192, Japan</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>24</day><month>7</month><year>2007</year></pub-date><volume>7</volume><fpage>69</fpage><lpage>69</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2180/7/69"/><history><date date-type="received"><day>21</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Yoshimura et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Yoshimura et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Yoshimura Mika y-mika@is.naist.jp </dc:author><dc:title> Involvement of the YneS/YgiH and PlsX proteins in phospholipid biosynthesis in both Bacillus subtilis and Escherichia coli </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Microbiology 7(1): 69-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2180(2007)7:1&#x0003c;69&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2180</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Phospholipid biosynthesis commences with the acylation of glycerol-3-phosphate (G3P) to form 1-acyl-G3P. This step is catalyzed by the PlsB protein in <italic>Escherichia coli</italic>. The gene encoding this protein has not been identified, however, in the majority of bacterial genome sequences, including that of <italic>Bacillus subtilis</italic>. Recently, a new two-step pathway catalyzed by PlsX and PlsY proteins for the initiation of phospholipid formation in <italic>Streptococcus pneumoniae </italic>has been reported.</p></sec><sec><title>Results</title><p>In <italic>B. subtilis</italic>, 271 genes have been reported to be indispensable, when inactivated singly, for growth in LB medium. Among these, 11 genes encode proteins with unknown functions. As part of a genetic study to identify the functions of these genes, we show here that the <italic>B. subtilis </italic>ortholog of <italic>S. pneumoniae </italic>PlsY, YneS, is required for G3P acyltransferase activity, together with PlsX. The <italic>B. subtilis </italic>genome lacks <italic>plsB</italic>, and we show in vivo that the PlsX/Y pathway is indeed essential for the growth of bacteria lacking <italic>plsB</italic>. Interestingly, in addition to <italic>plsB</italic>, <italic>E. coli </italic>possesses <italic>plsX </italic>and the <italic>plsY </italic>ortholog, <italic>ygiH</italic>. We therefore explored the functional relationship between PlsB, PlsX and YgiH in <italic>E. coli</italic>, and found that <italic>plsB </italic>is essential for <italic>E. coli </italic>growth, indicating that PlsB plays an important role in 1-acyl-G3P synthesis in <italic>E. coli</italic>. We also found, however, that the simultaneous inactivation of <italic>plsX </italic>and <italic>ygiH </italic>was impossible, revealing important roles for PlsX and YgiH in <italic>E. coli </italic>growth.</p></sec><sec><title>Conclusion</title><p>Both <italic>plsX </italic>and <italic>yneS </italic>are essential for 1-acyl-G3P synthesis in <italic>B. subtilis</italic>, in agreement with recent reports on their biochemical functions. In <italic>E. coli</italic>, PlsB plays a principal role in 1-acyl-G3P synthesis and is also essential for bacterial growth. PlsX and YgiH also, however, play important roles in <italic>E. coli </italic>growth, possibly by regulating the intracellular concentration of acyl-ACP. These proteins are therefore important targets for development of new antibacterial agents.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Phospholipids are major components of the cell membrane. Glycerol-3-phosphate (G3P) forms the backbone of all phospholipid molecules [<xref ref-type="bibr" rid="B1">1</xref>]. Phospholipid biosynthesis begins with two steps of G3P acylation, leading to the formation of phosphatidic acid (PA). In bacteria, PA is converted to CDP-diacylglycerol, the precursor of the three major phospholipids, phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CA) [<xref ref-type="bibr" rid="B2">2</xref>] (Figure <xref ref-type="fig" rid="F1">1</xref>). Earlier biochemical and genetic analyses disclosed that G3P and 1-acylglycerol-phosphate (1-acyl-G3P) acyltransferase are encoded by the <italic>plsB </italic>and <italic>plsC </italic>genes, respectively, in <italic>Escherichia coli </italic>[<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Interestingly, while <italic>plsC </italic>is universally conserved in eubacteria, <italic>plsB </italic>has been identified in only a limited number of species, mainly belonging to the gamma proteobacterial group. Another gene homologous to <italic>E. coli plsC</italic>, possibly encoding G3P acyltransferase, <italic>plsD</italic>, has been cloned from the <italic>Clostridium butyricum </italic>genome, based on its ability to complement <italic>plsB </italic>defects in <italic>E. coli</italic>. However, the role of <italic>plsD </italic>in <italic>C. butyricum </italic>cells is currently unclear [<xref ref-type="bibr" rid="B6">6</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Phospholipid synthesis pathway in <italic>B. subtilis</italic></bold>. Abbreviations: GpsA, NAD(P)H-dependent glycerol-3-phosphate dehydrogenase; GlpD, glycerol-3-phosphate dehydrogenase; GlpT, glycerol-3-phosphate permease; GlpF, glycerol uptake facilitator protein; GlpK, glycerol kinase; PlsC, 1-acylglycerol-3-phosphate O-acyltransferase; CdsA, phosphatidate cytidylyltransferase.</p></caption><graphic xlink:href="1471-2180-7-69-1"/></fig><p><italic>E. coli </italic>PlsB utilizes acyl-ACP (Acyl Carrier Protein) and acyl-CoA as acyl donors to synthesize 1-acyl-G3P [<xref ref-type="bibr" rid="B7">7</xref>]. Recently, Lu et al. [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>] have reported a new two-step pathway that utilizes a novel fatty acid intermediate for the initiation of phospholipid formation in <italic>Streptococcus pneumoniae</italic>. They demonstrated biochemically that PlsX produced a unique activated fatty acid by catalyzing the synthesis of fatty acyl-phosphate from acyl-ACP, and then showed that PlsY transferred the fatty acid moiety from acyl-phosphate (acyl-PO<sub>4</sub>) to G3P. The <italic>plsX </italic>gene is widely conserved in eubacteria and it had been suggested that this gene was involved in fatty acid and/or phospholipid synthesis in <italic>E. coli</italic>, although the exact role of the gene remained unknown [<xref ref-type="bibr" rid="B3">3</xref>]. In <italic>B. subtilis</italic>, PlsX is essential for growth [<xref ref-type="bibr" rid="B10">10</xref>] and PlsX expression is controlled by FapR, a protein that regulates fatty acid and phospholipid biosynthesis genes [<xref ref-type="bibr" rid="B11">11</xref>]. Although the <italic>plsY </italic>gene, encoding a membrane protein around 200 amino acids long, is also widely conserved in eubacteria [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>], the <italic>plsY </italic>gene function had been completely unknown.</p><p>In the gram-positive spore-forming bacterium,<italic>Bacillus subtilis</italic>, we showed that 271 genes, including <italic>plsC </italic>(<italic>yhdO</italic>) and <italic>plsX</italic>, when inactivated singly, were indispensable for growth in LB medium [<xref ref-type="bibr" rid="B10">10</xref>]. Among these genes, 11 encoded proteins with unknown functions, and these proteins are therefore targets for development of new antibacterial agents. As part of a genetic study to identify the functions of these genes, here we show that the <italic>B. subtilis </italic>ortholog of <italic>S. pneumoniae </italic>PlsY, YneS, is required for G3P acyltransferase activity, together with PlsX. The <italic>B. subtilis </italic>genome lacks <italic>plsB</italic>, and our results demonstrate in vivo that the PlsX/Y pathway is essential for the growth of bacteria lacking <italic>plsB</italic>. Interestingly, in addition to <italic>plsB</italic>, <italic>E. coli </italic>possesses <italic>plsX </italic>and the <italic>plsY </italic>ortholog, <italic>ygiH</italic>. Thus, we explored the functional relationship between PlsB, PlsX and YgiH in <italic>E. coli</italic>, and found that, although PlsB plays the principal role in 1-acyl-G3P synthesis, PlsX and YgiH are also important for optimal <italic>E. coli </italic>growth.</p></sec><sec><title>Results</title><sec><title>Isolation of a <italic>B. subtilis yneS-ts </italic>mutant</title><p>To explore the functions of essential genes of unknown function, we adopted a strategy to isolate temperature-sensitive (<italic>ts</italic>) mutants of these genes and then to seek extragenic suppressors of the <italic>ts </italic>genes. To generate a <italic>ts </italic>mutation in <italic>yneS</italic>, we initially introduced a nonfunctional chloramphenicol-resistant gene (<italic>cat</italic>) downstream of <italic>yneS</italic>, and transformed cells with the <italic>yneS</italic>-functional <italic>cat </italic>fragment mutagenized by PCR in vitro. Chloramphenicol-resistant transformants were selected at 30&#x000b0;C, and colonies that were unable to grow above 42&#x000b0;C were analyzed. In this manner, we isolated a <italic>ts </italic>mutant of <italic>yneS </italic>(strain MY103) that had a one-base substitution altering Val190 to Glu in the C-terminal cytoplasmic region of the protein.</p></sec><sec><title>Mapping of the suppressor mutation site in the <italic>yneS-ts sup-1 </italic>strain</title><p>Next, we isolated a spontaneous extragenic suppressor mutant of the <italic>ts </italic>phenotype (strain MY105, <italic>yneS-ts sup-1</italic>, Figure <xref ref-type="fig" rid="F2">2</xref>) by cultivation at the restrictive temperature. Transformation of wild-type strain 168 cells with chromosomal DNA of MY105 led to the <italic>ts </italic>growth of more than 90% of chloramphenicol-resistant transformants, indicating that the <italic>sup-1 </italic>mutation was not linked to the <italic>yneS </italic>gene. MY105 cells lost sporulation ability, and the Spo<sup>- </sup>phenotype was maintained in MY107 cells (Pspac::<italic>yneS sup-1</italic>) in which the <italic>yneS-ts </italic>gene was replaced with wild-type <italic>yneS </italic>under control of the IPTG-dependent Pspac promoter. A DNA fragment (ca. 8 kb) that complemented the Spo<sup>- </sup>phenotype of MY107 in trans was isolated from a <italic>B. subtilis </italic>genomic DNA library in which an <italic>Mbo</italic>I partial digest was ligated with the phage vector, &#x003c6;CM, as described previously [<xref ref-type="bibr" rid="B12">12</xref>]. The 8 kb fragment was cut into 2.5 kb and 5 kb fragments. The 5 kb fragment with the <italic>cat </italic>gene of the phage vector was cloned into pBR322, while the 2.5 kb fragment was ligated into pCA191 containing the <italic>cat </italic>gene [<xref ref-type="bibr" rid="B13">13</xref>]. MY107 cells were transformed with these plasmids for integration into the chromosome via single crossovers. The results indicated that the 5 kb fragment allowed recovery of the ability to sporulate, while the 2.5 kb fragment did not. Sequencing of the 5 kb fragment revealed three genes. These were the 3'-terminal region of <italic>glpF</italic>, encoding the glycerol uptake facilitator, and full-length <italic>glpK </italic>and <italic>glpD</italic>, encoding glycerol kinase and glycerol-3-phosphate dehydrogenase, respectively. Because <italic>glpF </italic>and <italic>glpK </italic>constitute an operon, and because the cloned 8 kb fragment did not contain the promoter sequence [<xref ref-type="bibr" rid="B14">14</xref>], <italic>glpK </italic>was possibly not expressed from the fragment cloned in &#x003c6;CM. The <italic>glpD </italic>promoter between <italic>glpK </italic>and <italic>glpD </italic>has, however, been identified [<xref ref-type="bibr" rid="B15">15</xref>]. These results suggested that the mutation(s) responsible for the Spo- phenotype mapped in the <italic>glpD </italic>gene. To confirm this theory, full-length wild type <italic>glpD </italic>(in pCA191<italic>glpD</italic>-FL), the 5'-terminal half of the gene (in pCA191<italic>glpD</italic>-N), and the 3'-terminal half (in pCA191<italic>glpD</italic>-C), were separately cloned into pCA191. The resulting constructs were integrated into the MY107 chromosome by single crossovers and the sporulation abilities of transformants were examined. The 5'-terminal region of <italic>glpD</italic>, and the full-length gene, conveyed the ability to sporulate, but the 3'-terminal <italic>glpD </italic>region did not. Sequencing of the 1.2 kb 5'-terminal half of <italic>glpD </italic>in MY103 (<italic>yneS-ts</italic>) revealed a single base (G) insertion between nucleotides C 492 and G 493, which resulted in inactivation of the gene. This result was consistent with the previous finding that <italic>glpD </italic>inactivation impairs sporulation ability [<xref ref-type="bibr" rid="B16">16</xref>].</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Growth properties of <italic>B. subtilis yneS-ts </italic>and suppressor mutants</bold>. <italic>B. subtilis </italic>wild-type (168), <italic>yneS-ts </italic>(strain MY103), <italic>yneS-ts sup-1 </italic>(strain MY105), and <italic>yneS-ts </italic>&#x00394;<italic>glpD</italic>::pMutinNC (strain MY109) cells were grown in LB, LB with 0.1% (v/v) glycerol, and LB with 0.1% (w/v) glycerol-3-phosphate, at 30&#x000b0;C and 45&#x000b0;C.</p></caption><graphic xlink:href="1471-2180-7-69-2"/></fig><p>We further confirmed that <italic>glpD </italic>inactivation suppressed the <italic>yneS-ts </italic>phenotype by insertion of a plasmid, pMutinNC [<xref ref-type="bibr" rid="B17">17</xref>], carrying an internal segment of the <italic>glpD </italic>gene, into the <italic>glpD </italic>gene of <italic>yneS-ts </italic>cells (strain MY109, <italic>yneS-ts</italic>, &#x00394;<italic>glpD</italic>::pMutin NC, Figure <xref ref-type="fig" rid="F2">2</xref>).</p></sec><sec><title>Increases in intracellular G3P concentration suppress the <italic>yneS-ts </italic>phenotype</title><p>The intracellular G3P concentration is known to be elevated in <italic>glpD </italic>mutants [<xref ref-type="bibr" rid="B16">16</xref>]. We speculated that increases in the G3P level might suppress the <italic>yneS</italic>-<italic>ts </italic>phenotype. Indeed, we found that supplementation of the growth medium (LB) with 0.1% (w/v) G3P, or glycerol, complemented the <italic>yneS-ts </italic>phenotype (Figure <xref ref-type="fig" rid="F2">2</xref>). Growth of MY105 (<italic>yneS-ts sup-1</italic>) and MY109 (<italic>yneS-ts</italic>, &#x00394;<italic>glpD</italic>::pMutinNC) cells was impaired compared to <italic>glpD</italic><sup>+ </sup>cells (wild type and <italic>yneS-ts </italic>cells), when glycerol or G3P was supplemented in the growth medium. This phenotype was also observed in MY108 (&#x00394;<italic>glpD</italic>::pMutinNC) cells (data not shown). Given that accumulation of G3P is known to result in abnormal septation and inhibition of sporulation [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>], an increase in the intracellular concentration of G3P would explain the growth impairment of cells without <italic>glpD</italic>. It should be noted that G3P and glycerol did not complement the growth defect resulting from YneS depletion in the IPTG-dependent <italic>yneS </italic>mutant cells, strain YNESp [<xref ref-type="bibr" rid="B10">10</xref>] (data not shown). The YneS-ts mutant protein will retain a reduced activity at high temperature, although the activity is insufficient to support cell growth. Residual activity would be enhanced by increases in the intracellular concentrations of G3P or glycerol.</p></sec><sec><title>Phospholipid synthesis in <italic>B. subtilis plsC</italic>-<italic>ts</italic>, <italic>yneS-ts</italic>, and IPTG-dependent <italic>plsX </italic>mutants, under restrictive conditions</title><p>G3P is a substrate for G3P acyltransferase, and inhibition of G3P acyltransferase activity as a result of simultaneous mutations in <italic>plsB </italic>and <italic>plsX </italic>in <italic>E. coli </italic>led to G3P auxotrophy [<xref ref-type="bibr" rid="B3">3</xref>]. Accordingly, we examined the involvement of YneS in 1-acyl-G3P synthesis by analyzing phospholipid synthesis in <italic>yneS-ts </italic>cells at the restrictive temperature. We additionally constructed mutations in genes possibly involved in phospholipid synthesis. These included a <italic>ts </italic>mutation in <italic>plsC</italic>, in which 7 C-terminal residues were deleted (strain MY112), and an IPTG-dependent <italic>plsX </italic>mutation in strain MY111.</p><p>To determine phospholipid biosynthesis rates, <italic>B. subtilis </italic>cells were pulse-labeled with <sup>32 </sup>[Pi] for 5 min. Phospholipids were extracted using the method of Bligh and Dyer [<xref ref-type="bibr" rid="B20">20</xref>], and separated by two-dimensional thin layer chromatography [<xref ref-type="bibr" rid="B5">5</xref>]. We detected PA, PG, PE, and CL in wild-type cells growing at either 30&#x000b0;C or 42&#x000b0;C (Figure <xref ref-type="fig" rid="F3">3A</xref>). When <italic>plsC</italic>-<italic>ts </italic>cells were labeled at 30&#x000b0;C, a pattern similar to that of wild-type cells was obtained. At the restrictive temperature, however, 1-acyl-G3P accumulation was observed, and phospholipid synthesis did not take place (Figure <xref ref-type="fig" rid="F3">3B</xref>). This is consistent with the known 1-acyl-G3P acyltransferase activity of PlsC. In contract, no phospholipids were detectable in <italic>yneS-ts </italic>cells following a shift to the restrictive temperature (Figure <xref ref-type="fig" rid="F3">3C</xref>). Our data indicate that YneS inactivation results in blockage of the first step in phospholipid synthesis in <italic>B. subtilis </italic>cells. Furthermore, PlsX depletion in IPTG-dependent mutant cells induces a similar change in phospholipid composition (Figure <xref ref-type="fig" rid="F3">3D</xref>). The results are consistent with the two-step mechanism of 1-acyl-G3P synthesis reported by Lu <italic>et al</italic>. [<xref ref-type="bibr" rid="B8">8</xref>], and show that the PlsX/Y pathway is essential for growth of <italic>B. subtilis </italic>lacking <italic>plsB</italic>.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Phospholipid synthesis in <italic>B. subtilis yneS-ts</italic>, <italic>plsC</italic>-<italic>ts</italic>, and IPTG-dependent <italic>plsX </italic>mutants, under restrictive conditions</bold>. Labeling with <sup>32 </sup>[Pi] for 5 min, lipid isolation, lipid separation using two-dimensional TLC, and phospholipid detection, are described in Methods. (A) Wild-type cells labeled at 30&#x000b0;C and 42&#x000b0;C. (B) <italic>plsC</italic>-<italic>ts </italic>cells (strain MY112) labeled at 30&#x000b0;C and 42&#x000b0;C. (C) <italic>yneS-ts </italic>cells (strain MY103) labeled at 30&#x000b0;C and 42&#x000b0;C. (D) Pspac-<italic>plsX </italic>cells (strain MY111) labeled in the presence and absence of IPTG. Abbreviations: 1-acyl-G3P, 1-acylglycerol-phosphate; PA, phosphatidic acid; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; CA, cardiolipin.</p></caption><graphic xlink:href="1471-2180-7-69-3"/></fig></sec><sec><title>Functional relationship between <italic>plsB, plsX </italic>and <italic>yneS/ygiH </italic>in <italic>E. coli</italic></title><p>It is generally believed that <italic>E. coli plsB </italic>is essential for bacterial growth, although experimental evidence supporting this hypothesis has yet to be obtained, and transposon mutagenesis experiments suggested that <italic>plsX </italic>is dispensable in <italic>E. coli </italic>[<xref ref-type="bibr" rid="B21">21</xref>]. The ortholog of <italic>S. pneumoniae plsY </italic>and <italic>B. subtilis yneS </italic>in <italic>E. coli</italic>, <italic>ygiH</italic>, is yet another dispensable gene [<xref ref-type="bibr" rid="B21">21</xref>]. Accordingly, we determined the functional relationship between <italic>plsB</italic>, <italic>plsX</italic>, and <italic>ygiH</italic>, in <italic>E. coli</italic>.</p><p>We initially attempted to systematically inactivate <italic>E. coli </italic>genes either singly or in combination. For this purpose, we replaced the <italic>plsX </italic>and <italic>ygiH </italic>genes with a kanamycin-resistance gene (<italic>kan</italic>) using the method of Datsenko and Wanner [<xref ref-type="bibr" rid="B22">22</xref>]. Inactivation of <italic>plsB </italic>was performed in the presence of plasmid-borne <italic>plsB</italic>. Phage P1 transduction frequencies of each allele into cells of various genetic backgrounds were measured to avoid possible effects of secondary mutations arising during gene inactivation (the <italic>kan </italic>cassette was removed, using FLP recombinase, in recipient cells for P1 transduction). The results, summarized in Table <xref ref-type="table" rid="T1">1</xref>, show that <italic>plsB </italic>is essential for <italic>E. coli </italic>growth, while single deletions of either <italic>plsX </italic>or <italic>ygiH </italic>do not affect cell growth. These results suggested that PlsB plays a principal role in G3P acyltransferase activity in <italic>E. coli</italic>. Additionally, to examine whether <italic>plsB </italic>function might be complemented by overexpression of other genes, we introduced derivatives of plasmid pSTV28 or pSTV29 (12&#x02013;15 copies per cell) harboring <italic>E. coli plsX </italic>and <italic>ygiH</italic>, and <italic>B. subtilis plsX </italic>and <italic>yneS </italic>into recipient strains for P1 transduction, without restoration of <italic>plsB </italic>function. Unexpectedly, although single deletions of <italic>plsX </italic>or <italic>ygiH </italic>did not affect cell growth, we found that the simultaneous inactivation of <italic>plsX </italic>and <italic>ygiH </italic>was impossible (Table <xref ref-type="table" rid="T2">2</xref>), indicating that <italic>plsX </italic>and <italic>ygiH </italic>also have important roles in <italic>E. coli </italic>growth. Next, we expressed <italic>B. subtilis plsX </italic>and <italic>yneS </italic>genes in <italic>E. coli</italic>, and also the corresponding <italic>E. coli </italic>genes (as controls). The lethal phenotype of the <italic>plsX </italic>and <italic>ygiH </italic>double deletion was suppressed by <italic>B. subtilis plsX </italic>or <italic>yneS</italic>, indicating that these genes were able to complement the <italic>plsX </italic>and <italic>ygiH E. coli </italic>gene activities. In addition, a <italic>plsX </italic>and <italic>ygiH </italic>double deletion was possible when <italic>plsB </italic>was overexpressed from pSTV29<italic>plsB</italic>. To obtain further insights into the functional relationships between <italic>plsB</italic>, <italic>plsX </italic>and <italic>ygiH</italic>, we next introduced a plasmid harboring a mutated <italic>plsB </italic>gene (<italic>plsB26</italic>) into <italic>E. coli</italic>, and then attempted to inactivate <italic>plsB</italic>, <italic>plsX </italic>or <italic>ygiH </italic>(Table <xref ref-type="table" rid="T3">3</xref>). The <italic>plsB26 </italic>gene has a point mutation that changes Gly1045 to Ala, reducing the affinity of PlsB26 for G3P [<xref ref-type="bibr" rid="B23">23</xref>]. In the presence of plasmid-borne <italic>plsB26</italic>, genomic <italic>plsB </italic>could be inactivated, indicating that PlsB26 protein expressed from the plasmid-borne gene could support <italic>E. coli </italic>growth. The plasmid-borne gene could not, however, complement the lethality of the <italic>plsX </italic>and <italic>ygiH </italic>double deletion. Furthermore, while native <italic>plsB </italic>could be inactivated in the presence of pSVT29<italic>plsB26 </italic>in cells lacking functional <italic>ygiH</italic>, <italic>plsB </italic>inactivation became impossible in cells with inactivated <italic>plsX</italic>, indicating that PlsX activity becomes indispensable for the growth of cells when the <italic>plsB </italic>activity is supplied by a plasmid copy of <italic>plsB26</italic>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Frequency of P1 transduction of <italic>plsB</italic>::<italic>kan</italic>, <italic>plsX</italic>::<italic>kan</italic>, and <italic>ygiH</italic>::<italic>kan </italic>mutations into W3110 cells harboring various plasmids</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="9">Recipient strain</td><td align="center" colspan="3">Relative transduction frequency*</td></tr><tr><td colspan="9"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td align="center" colspan="2">Chromosomal gene</td><td align="center" colspan="6">Harboring plasmids</td><td align="center" colspan="3">P1 donor strain</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td colspan="6"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td align="center">Strain</td><td align="center"><italic>plsX</italic></td><td align="center"><italic>ygiH</italic></td><td align="center">pSTV29</td><td align="center">pSTV29 <italic>plsB</italic></td><td align="center">pSTV28 <italic>EcplsX</italic></td><td align="center">pSTV29 <italic>ygiH</italic></td><td align="center">pSTV28 <italic>BsplsX</italic></td><td align="center">pSTV29 <italic>yneS</italic></td><td align="center">&#x00394;<italic>plsB::kan</italic></td><td align="center">&#x00394;<italic>plsX::kan</italic></td><td align="center">&#x00394;<italic>ygiH::kan</italic></td></tr></thead><tbody><tr><td align="center">W3110</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">100</td><td align="center">100</td></tr><tr><td align="center">MEC104</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">50</td><td align="center">64.3</td></tr><tr><td align="center">MEC105</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">100</td><td align="center">65.5</td><td align="center">58.9</td></tr><tr><td align="center">MEC106</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">80</td><td align="center">50.9</td></tr><tr><td align="center">MEC107</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">100</td><td align="center">78</td></tr><tr><td align="center">MEC108</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">0</td><td align="center">63.6</td><td align="center">100</td></tr><tr><td align="center">MEC109</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">0</td><td align="center">81.8</td><td align="center">70.6</td></tr></tbody></table><table-wrap-foot><p>*Transduction frequencies are expressed as percentages of the highest number of Km<sup>r </sup>colonies recorded in each experiment, and are depicted as blocks.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Frequency of P1 transduction of <italic>plsB</italic>::<italic>kan</italic>, <italic>plsX</italic>::<italic>kan</italic>, and <italic>ygiH</italic>::<italic>kan </italic>mutations into strains MEC102 and MEC103 harboring various plasmids</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="9">Recipient strain</td><td align="center" colspan="3">Relative transduction frequency*</td></tr><tr><td colspan="9"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td align="center" colspan="2">Chromosomal gene</td><td align="center" colspan="6">Harboring plasmids</td><td align="center" colspan="3">P1 donor strain</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td colspan="6"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td align="center">Strain</td><td align="center"><italic>plsX</italic></td><td align="center"><italic>ygiH</italic></td><td align="center">pSTV29</td><td align="center">pSTV29 <italic>plsB</italic></td><td align="center">pSTV28 <italic>EcplsX</italic></td><td align="center">pSTV29 <italic>ygiH</italic></td><td align="center">pSTV28 <italic>BsplsX</italic></td><td align="center">pSTV29 <italic>yneS</italic></td><td align="center">&#x00394;<italic>plsB::kan</italic></td><td align="center">&#x00394;<italic>plsX::kan</italic></td><td align="center">&#x00394;<italic>ygiH::kan</italic></td></tr></thead><tbody><tr><td align="center">MEC102</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">100</td><td align="center">0</td></tr><tr><td align="center">MEC103</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">0</td><td align="center">100</td></tr><tr><td align="center">MEC110</td><td align="center">-</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">55.9</td><td align="center">0</td></tr><tr><td align="center">MEC111</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">100</td><td align="center">53.5</td><td align="center">59.8</td></tr><tr><td align="center">MEC112</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">56.3</td><td align="center">75.3</td></tr><tr><td align="center">MEC113</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">83.1</td><td align="center">100</td></tr><tr><td align="center">MEC114</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">0</td><td align="center">45.1</td><td align="center">84.2</td></tr><tr><td align="center">MEC115</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">0</td><td align="center">100</td><td align="center">92.7</td></tr><tr><td align="center">MEC116</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">0</td><td align="center">69.8</td></tr><tr><td align="center">MEC117</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">100</td><td align="center">63.7</td><td align="center">85.9</td></tr><tr><td align="center">MEC118</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">99.5</td><td align="center">100</td></tr><tr><td align="center">MEC119</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">85.1</td><td align="center">73.8</td></tr><tr><td align="center">MEC120</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">0</td><td align="center">36.3</td><td align="center">60.5</td></tr><tr><td align="center">MEC121</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">0</td><td align="center">100</td><td align="center">96</td></tr></tbody></table><table-wrap-foot><p>*Transduction frequencies are expressed as percentages of the highest number of Km<sup>r </sup>colonies recorded in each experiment, and are depicted as blocks.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Frequency of P1 transduction of <italic>plsB</italic>::<italic>kan</italic>, <italic>plsX</italic>::<italic>kan</italic>, and <italic>ygiH</italic>::<italic>kan </italic>mutations into W3110, strain MEC102, and strain MEC103, harboring pSTV29 <italic>-plsB </italic>and <italic>plsB26</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="6">Recipient strain</td><td align="center" colspan="3">Relative transduction frequency*</td></tr><tr><td colspan="6"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td align="center" colspan="2">Chromosomal gene</td><td align="center" colspan="3">Harboring plasmids</td><td align="center" colspan="3">P1 donor strain</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td colspan="3"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td align="center">Strain</td><td align="center"><italic>plsX</italic></td><td align="center"><italic>ygiH</italic></td><td align="center">pSTV29</td><td align="center">pSTV29 <italic>plsB</italic></td><td align="center">pSTV29 <italic>plsB26</italic></td><td align="center">&#x00394;<italic>plsB::kan</italic></td><td align="center">&#x00394;<italic>plsX::kan</italic></td><td align="center">&#x00394;<italic>ygiH::kan</italic></td></tr></thead><tbody><tr><td align="center">MEC104</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">66.4</td><td align="center">76.9</td></tr><tr><td align="center">MEC105</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">100</td><td align="center">100</td><td align="center">100</td></tr><tr><td align="center">MEC288</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">61.9</td><td align="center">67.7</td><td align="center">55.1</td></tr><tr><td align="center">MEC110</td><td align="center">-</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">98.2</td><td align="center">0</td></tr><tr><td align="center">MEC111</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">100</td><td align="center">75</td><td align="center">100</td></tr><tr><td align="center">MEC289</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">0</td><td align="center">100</td><td align="center">0</td></tr><tr><td align="center">MEC116</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">0</td><td align="center">100</td></tr><tr><td align="center">MEC117</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">100</td><td align="center">100</td><td align="center">89</td></tr><tr><td align="center">MEC290</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">59.3</td><td align="center">0</td><td align="center">61.7</td></tr></tbody></table><table-wrap-foot><p>*Transduction frequencies are expressed as percentages of the highest number of Km<sup>r </sup>colonies recorded in each experiment, and are depicted as blocks.</p></table-wrap-foot></table-wrap><p>The essential nature of <italic>plsB</italic>, and the lethality of the <italic>plsX </italic>and <italic>ygiH </italic>double deletion, were further confirmed using inducible forms of these genes. To this end, we placed the coding sequences of <italic>plsB, plsX </italic>and <italic>ygiH </italic>under the control of an IAA (3&#x003b2;-indoleacrylic acid)-inducible <italic>trp </italic>promoter (Pw), integrated the genes into the chromosome as described in Methods, and then deleted the native copies of either <italic>plsB </italic>alone, or both <italic>plsX </italic>and <italic>ygiH</italic>. As expected, strains MEC201 (Pw-<italic>plsB, &#x00394;plsB</italic>), MEC306 (Pw-<italic>plsX, &#x00394;plsX, &#x00394;ygiH</italic>) and MEC307 (Pw-<italic>ygiH, &#x00394;plsX</italic>, &#x00394;<italic>ygiH</italic>) cells displayed IAA-dependent growth (Figure <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4B</xref>).</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Growth properties of <italic>E. coli </italic>strains harboring IAA-inducible genes</bold>. <italic>E. coli </italic>strains harboring IAA-inducible genes were grown in LB medium containing 50 &#x003bc;g/ml ampicillin, with or without IAA (100 &#x003bc;g/ml), at 37&#x000b0;C. (A) a; MEC199 (Pw-<italic>plsB</italic>), b; MEC201 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB</italic>), c; MEC212 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>pSTV29 pMW118), d; MEC214 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>pSTV29 pMW118<italic>yneS</italic>), e; MEC218 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>pSTV29<italic>BsplsX </italic>pMW118), and f; MEC220 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>pSTV29<italic>BsplsX </italic>pMW118<italic>yneS</italic>). (B) a; MEC308 (Pw-<italic>EcplsX</italic>), b; MEC309 (Pw-<italic>ygiH</italic>), c; MEC306 (Pw-<italic>EcplsX &#x00394;plsX &#x00394;ygiH</italic>), and d; MEC307 (Pw-<italic>ygiH &#x00394;plsX &#x00394;ygiH</italic>). (C) <italic>E. coli </italic>strains harboring pUC18S or pUC18S <italic>tesA </italic>were grown in LB medium containing 50 &#x003bc;g/ml spectinomycin, with or without IAA (50 &#x003bc;g/ml), at 30&#x000b0;C. a; MEC323 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>&#x00394;<italic>ygiH </italic>pUC18S), b; MEC324 (Pw-<italic>plsB </italic>&#x00394;<italic>plsB </italic>&#x00394;<italic>ygiH </italic>pUC18S <italic>tesA</italic>), c; MEC325 (Pw-<italic>EcplsX &#x00394;plsX &#x00394;ygiH </italic>pUC18S), d; MEC326 (Pw-<italic>EcplsX &#x00394;plsX &#x00394;ygiH </italic>pUC18S <italic>tesA</italic>), e; MEC327 (Pw-<italic>ygiH &#x00394;plsX &#x00394;ygiH </italic>pUC18S), e; MEC328 (Pw-<italic>ygiH &#x00394;plsX &#x00394;ygiH </italic>pUC18S <italic>tesA</italic>).</p></caption><graphic xlink:href="1471-2180-7-69-4"/></fig><p>The PlsB and PlsX enzymes utilize acyl-ACP as acyl-donor, and abnormal accumulation of acyl-ACP has been shown to result in growth impairment [<xref ref-type="bibr" rid="B24">24</xref>]. To examine acyl-ACP accumulation in cells with inactivated <italic>plsX </italic>and <italic>ygiH </italic>genes, we introduced a derivative of pUC18, harboring the <italic>E. coli tesA </italic>gene encoding thioesterase I [<xref ref-type="bibr" rid="B25">25</xref>], into cells of strains MEC306 and MEC307. Interestingly, the growth defects of these strains in the absence of IAA were suppressed by the additional supply of thioesterase I (TesA hydrolyses acyl-ACP) (Figure <xref ref-type="fig" rid="F4">4C</xref>). We have not yet succeeded in demonstrating the expected TesA-dependent suppression of the inability to achieve <italic>plsX </italic>inactivation when <italic>plsB </italic>activity is supplied by a plasmid encoding <italic>plsB26</italic>. This is because it is difficult to construct an appropriate strain in which to examine the hypothesis.</p></sec><sec><title>Complementation of the PlsB activity by a combination of PlsX and YneS/YgiH</title><p>As we found that the combination of PlsX and YneS conferred the ability to synthesize 1-acyl-G3P upon <italic>B. subtilis</italic>, we expected that simultaneous overexpression of these two proteins would complement a <italic>plsB </italic>mutation in <italic>E. coli</italic>. To test this hypothesis, we introduced various combinations of plasmids harboring <italic>plsX </italic>and <italic>yneS</italic>/<italic>ygiH </italic>into <italic>E. coli </italic>cells. In these experiments, we employed derivatives of plasmid pMW118 (ca. 5 copies per cell), whose replication is compatible with that of pSTV28/29 derivatives, when more than one cloned gene was to be expressed. We successfully complemented the <italic>E. coli plsB </italic>mutation by expression of <italic>B. subtilis plsX </italic>and <italic>yneS </italic>(Table <xref ref-type="table" rid="T4">4</xref>). The complementation of the <italic>E. coli </italic>PlsB activity by the <italic>B. subtilis </italic>PlsX and YneS combination was also demonstrated using an IAA-inducible <italic>plsB </italic>gene (Figure <xref ref-type="fig" rid="F4">4A</xref>). Other gene combinations, including those with <italic>E. coli </italic>genes, did not complement <italic>plsB</italic>. Plasmid pMW118<italic>ygiH </italic>complemented the growth defect of MEC306 and MEC307 cells in the absence of IAA (data not shown), indicating that functional YgiH is expressed from pMW118<italic>ygiH</italic>. Although we could not determine the expression levels of the various proteins due to the lack of appropriate antibodies, the specific activities of <italic>E. coli </italic>PlsX and YgiH may be lower than those of their <italic>B. subtilis </italic>counterparts.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Frequency of P1 transduction of <italic>plsB</italic>::<italic>kan</italic>, <italic>plsX</italic>::<italic>kan</italic>, and <italic>ygiH</italic>::<italic>kan </italic>mutations into W3110 cells harboring various pairs of plasmids.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="9">Recipient strain</td><td align="center" colspan="3">Relative transduction frequency*</td></tr><tr><td colspan="9"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td align="center" colspan="2">Chromosomal gene</td><td align="center" colspan="6">Harboring plasmids</td><td align="center" colspan="3">P1 donor strain</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td colspan="6"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td align="center">Strain</td><td align="center"><italic>plsX</italic></td><td align="center"><italic>ygiH</italic></td><td align="center">pSTV29</td><td align="center">pSTV28 <italic>EcplsX</italic></td><td align="center">pSTV28 <italic>BsplsX</italic></td><td align="center">pMW118</td><td align="center">pMW118 <italic>ygiH</italic></td><td align="center">pMW118 <italic>yneS</italic></td><td align="center">&#x00394;<italic>plsB::kan</italic></td><td align="center">&#x00394;<italic>plsX::kan</italic></td><td align="center">&#x00394;<italic>ygiH::kan</italic></td></tr></thead><tbody><tr><td align="center">MEC130</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">56.1</td><td align="center">39.4</td></tr><tr><td align="center">MEC134</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">0</td><td align="center">53.7</td><td align="center">41.3</td></tr><tr><td align="center">MEC136</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">0</td><td align="center">100</td><td align="center">81.7</td></tr><tr><td align="center">MEC137</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">87.8</td><td align="center">69.2</td></tr><tr><td align="center">MEC139</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">0</td><td align="center">73.2</td><td align="center">100</td></tr><tr><td align="center">MEC140</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">0</td><td align="center">90.2</td><td align="center">46.2</td></tr><tr><td align="center">MEC142</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">100</td><td align="center">97.6</td><td align="center">90.4</td></tr></tbody></table><table-wrap-foot><p>*Transduction frequencies are expressed as percentages of the highest number of Km<sup>r </sup>colonies recorded in each experiment, and are depicted as blocks.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>Our genetic studies have shown that PlsX and YneS (now renamed PlsY) are essential for G3P acyltransferase activity in <italic>B. subtilis </italic>cells, and that the combination of the two <italic>B. subtilis </italic>proteins complements PlsB activity in <italic>E. coli </italic>cells. Our findings are consistent with the two-step mechanism of 1-acyl-G3P synthesis reported by Lu <italic>et al</italic>. [<xref ref-type="bibr" rid="B8">8</xref>], and we have shown that the PlsX/Y pathway is essential for the growth of <italic>B. subtilis </italic>lacking <italic>plsB</italic>. The combination of <italic>plsX </italic>and <italic>plsY </italic>is widely conserved in eubacteria, but most eubacteria lack <italic>plsB </italic>[<xref ref-type="bibr" rid="B8">8</xref>], strongly suggesting that <italic>plsX/Y </italic>will be essential genes in these bacteria.</p><p>A number of bacteria, belonging mainly to the gamma group of proteobacteria, possess both <italic>plsB </italic>and <italic>plsX</italic>/<italic>plsY</italic>, however. Another important finding reported here is that, in such cases, the relationship between the two 1-acyl-G3P synthesis pathways may be variable and complex. Although <italic>plsB </italic>has been reported to be dispensable in <italic>Pseudomonas aeruginosa </italic>[<xref ref-type="bibr" rid="B26">26</xref>], we found that the gene is indispensable in <italic>E. coli</italic>, indicating that PlsB is principally responsible for 1-acyl-G3P synthesis in <italic>E. coli</italic>. On the other hand, we found that simultaneous inactivation of both PlsX and PlsY is impossible, and that this lethality was complemented by overexpression of PlsB. As single deletions in either <italic>plsX </italic>or <italic>ygiH </italic>did not affect cell growth, the lethality of the <italic>plsX </italic>and <italic>ygiH </italic>double deletion cannot be because of inactivation of a minor pathway (using acyl-PO<sub>4</sub>) for 1-acyl-G3P synthesis.</p><p>Interestingly, PlsX activity becomes indispensable for growth of <italic>E. coli </italic>cells in which PlsB activity is supplied from a plasmid copy of <italic>plsB26</italic>. Growth, in minimal medium, of <italic>E. coli </italic>SJ22 cells harboring the <italic>plsB </italic>mutation on the chromosome is dependent on a supply of exogenous G3P. Depletion of G3P in the growth medium has been found to result in accumulation of acyl-ACP due to the blockage of 1-acyl-G3P synthesis, leading to a severe reduction in fatty acid biosynthesis because accumulated acyl-ACP causes feedback inhibition of enzymes in the biosynthetic pathway [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. G3P-acyltransferase activity expressed from a plasmid-borne copy of <italic>plsB26 </italic>may be less than that in wild type cells, and acyl-ACP may therefore accumulate in such cells. PlsX may be able to suppress the deleterious accumulation of acyl-ACP by converting acyl-ACP to acyl-PO<sub>4</sub>. PlsY may also be involved in control of the intracellular acyl-ACP concentration. <italic>E. coli </italic>PlsB has been shown to utilize both acyl-ACP and acyl-CoA as acyl donors in the synthesis of 1-acyl-G3P [<xref ref-type="bibr" rid="B7">7</xref>], but does not use these donors to make acyl-PO<sub>4 </sub>[<xref ref-type="bibr" rid="B8">8</xref>]. On the other hand, <italic>S. pneumoniae </italic>PlsY has been shown to synthesize 1-acyl-G3P using both acyl-ACP and acyl-PO<sub>4</sub>. These results suggest that <italic>E. coli </italic>PlsY, in the absence of PlsX, may synthesize 1-acyl-G3P using acyl-ACP, and this activity would then contribute to consumption of acyl-ACP. It is therefore possible that both PlsX and PlsY contribute independently to the maintenance of an appropriate intracellular acyl-ACP concentration, and simultaneous inactivation of both proteins therefore results in deleterious accumulation of acyl-ACP. Overexpression of PlsB increases 1-acyl-G3P synthesis activity and may suppress the accumulation of acyl-ACP resulting from the <italic>plsX </italic>and <italic>ygiH </italic>double deletion. Suppression of growth defects due to the <italic>plsX </italic>and <italic>ygiH </italic>double deletion by overexpression of thioesterase I strongly supports our hypothesis.</p><p>Acyl-ACP has been shown to be not only a central cofactor for fatty acid and phospholipid synthesis, but also a regulatory molecule, coordinating the synthesis of these lipids with cell growth. Our results strongly suggest that PlsX, PlsY and PlsB form a complex network functioning to supply appropriate levels of lipid biosynthetic precursors, especially acyl-ACP. In turn, this controls the synthesis of 1-acyl-G3P in <italic>E. coli </italic>cells, resulting in appropriate levels of 1-acyl-G3P under various growth conditions. Further studies are needed to reveal the precise roles of PlsX, PlsY and PlsB.</p></sec><sec><title>Conclusion</title><p>Both <italic>plsX </italic>and <italic>yneS </italic>are essential for 1-acyl-G3P synthesis in <italic>B. subtilis </italic>cells lacking <italic>plsB</italic>, in agreement with recent reports on the biochemical functions of these genes. Both genes will be essential for bacterial growth lacking <italic>plsB</italic>. In <italic>E. coli</italic>, PlsB plays a principal role in 1-acyl-G3P synthesis and is also essential for bacterial growth. PlsX and YgiH also, however, play important roles in <italic>E. coli </italic>growth, probably by regulating the intracellular concentrations of acyl-ACP at appropriate levels. These proteins are therefore important targets for the development of new antibacterial reagents.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Materials and strains</title><p>The <italic>B. subtilis </italic>and <italic>E. coli </italic>strains used in this study are listed in Tables S1 [see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>] and S2 [see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>], respectively. Primers and plasmids are specified in Tables S3 [see Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>] and S4 [see Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>], respectively. <italic>B. subtilis </italic>cells were transformed as described previously [<xref ref-type="bibr" rid="B29">29</xref>]. <italic>E. coli </italic>strains DH5&#x003b1; (Takara) and JM105 (Takara), were used throughout as cloning hosts.</p><p>Full-length sequences of <italic>E. coli plsB</italic>, <italic>plsX </italic>(<italic>EcplsX</italic>), and <italic>ygiH</italic>, and <italic>B. subtilis plsX </italic>(<italic>BsplsX</italic>) and <italic>yneS</italic>, were amplified and cloned into plasmids pSTV28 or pSTV29 (Takara, 12&#x02013;15 copies per cell) as summarized in Table S3 [see Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>]. A DNA fragment containing a mutated <italic>plsB </italic>sequence, <italic>plsB26</italic>, was PCR-amplified from genomic DNA of <italic>E. coli </italic>strain TL84 [<xref ref-type="bibr" rid="B3">3</xref>], and cloned into pSTV29. Inserts of pSTV29<italic>ygiH </italic>and pSTV29<italic>yneS </italic>were transferred into pMW118 (Nippon Gene, ca. 5 copies per cell), because the replication of pMW118 is compatible with that of pSTV28 and pSTV29.</p><p>The IAA (3&#x003b2;-indoleacrylic acid, Sigma)-inducible <italic>trp </italic>promoter fragment was PCR amplified from W3110 chromosomal DNA. The PCR product was digested with the restriction enzymes <italic>Mun</italic>I and <italic>Eco</italic>RI, and cloned into the <italic>Eco</italic>RI site of pMC1403 [<xref ref-type="bibr" rid="B30">30</xref>], generating pMC1403Pw. Full-length sequences of <italic>E. coli plsB</italic>, <italic>plsX</italic>, and <italic>ygiH </italic>were amplified and cloned into the <italic>Eco</italic>RI/<italic>Bam</italic>HI, <italic>Bam</italic>HI, or <italic>Eco</italic>RI/<italic>Bam</italic>HI sites of pMC1403-Pw, respectively, to obtain pMC1403Pw-<italic>plsB</italic>, pMC1403Pw-<italic>plsX </italic>and pMC1403Pw-<italic>ygiH</italic>.</p><p>The full-length sequence of <italic>E. coli tesA </italic>was amplified and cloned into plasmid pUC18S. Plasmid pUC18S was created by replacing the <italic>Aat</italic>II/<italic>Eam</italic>1105I fragment (containing the ampicillin-resistance gene) of pUC18 (Takara) with an <italic>Aat</italic>II/<italic>Eam</italic>1105I fragment (containing the spectinomycin-resistance gene) amplified, by PCR, from pAPNC213 [<xref ref-type="bibr" rid="B17">17</xref>].</p><p><italic>B. subtilis </italic>strains were grown in Luria-Bertani (LB) medium, or DSM, supplemented with chloramphenicol (5 &#x003bc;g/ml), kanamycin (5 &#x003bc;g/ml), or erythromycin (0.5 &#x003bc;g/ml), as appropriate.<italic>E. coli </italic>strains were grown in LB or M9 minimal media, supplemented with ampicillin (50 &#x003bc;g/ml), chloramphenicol (5 &#x003bc;g/ml), spectinomycin (50 &#x003bc;g/ml), or kanamycin (25 &#x003bc;g/ml), as appropriate.</p></sec><sec><title>Isolation of the <italic>B. subtilis yneS-ts </italic>mutant</title><p>The <italic>yneS-ts </italic>mutant was isolated according to the procedure of F. Kawamura (personal communication). The <italic>B. subtilis </italic>strain MY101, in which the sequence 45&#x02013;103 bp downstream of the termination codon of <italic>yneS </italic>(in the coding sequence of <italic>yneR</italic>, which is downstream of <italic>yneS</italic>) was replaced with a <italic>cat </italic>gene, was generated as follows. The regions upstream and downstream of the insertion site were amplified by PCR using a yneS-F1 and yneS-R1 primer pair, and a yneS-F2 and yneS-R2 primer pair, respectively. The <italic>cat </italic>gene of pCBB31 [<xref ref-type="bibr" rid="B31">31</xref>] was amplified using primers cat-F and cat-R. The primer pairs yneS-R1 and cat-R, and cat-F and yneS-F2, contain overlapping sequences, and the three fragments obtained were ligated by recombinant PCR using yneS-F1 and yneS-R2 primers. <italic>B. subtilis </italic>strain 168 was transformed with the resulting fragment, and chloramphenicol-resistant transformants were selected (MY101, &#x00394;<italic>yneR</italic>::<italic>cat</italic><sup>+</sup>). Next, the pCH11 plasmid containing an inactive <italic>cat </italic>gene (a nonsense mutation is located in the gene), a kanamycin-resistance gene, and a <italic>ts </italic>origin of replication, was introduced into MY101. We selected for kanamycin resistance and chloramphenicol sensitivity in order to isolate cells with the inactive <italic>cat </italic>gene on the chromosome, which occurred when gene conversion from the plasmid copy was successful [<xref ref-type="bibr" rid="B32">32</xref>]. The introduced plasmid was removed by cultivation at the temperature restrictive for pCH11 replication, to generate strain MY102 (&#x00394;<italic>yneR</italic>::<italic>cat</italic><sup>-</sup>). PCR mutagenesis of the <italic>yneS-cat </italic>fragment was performed using r<italic>Taq </italic>polymerase (Takara) with MY101 chromosomal DNA as template. The mutated <italic>yneS-cat </italic>fragment was used to transform strain MY102. Chloramphenicol-resistant transformants were selected at 30&#x000b0;C, and colonies that were unable to grow above 42&#x000b0;C were screened to isolate strain MY103 (<italic>yneS-ts</italic>).</p></sec><sec><title>Construction of the <italic>B. subtilis plsC-ts </italic>mutant</title><p>As the growth of cells in which <italic>gfp </italic>(encoding green fluorescent protein) was translationally fused to the C-terminus of PlsC became temperature-sensitive (data not shown), we predicted that the required <italic>plsC</italic>-<italic>ts </italic>mutant could be obtained by modification of the C-terminal region of the <italic>plsC </italic>gene. We therefore created a series of mutants with deletions of different numbers of amino acids from the C-terminus of PlsC and found that deletion of the 7 end residues resulted in a <italic>ts </italic>phenotype (strain MY112). To generate strain MY112, the 3' end of the <italic>plsC </italic>coding region (with the 7 codons deleted) was amplified, and a termination codon was added by PCR using the primers plsC-F1 and plsC-C&#x00394;7-R1. The region downstream of <italic>plsC </italic>was amplified with the oligonucleotides plsC-F2 and plsC-R2. The two fragments were ligated to the 5' and 3' ends of the <italic>cat </italic>gene (amplified from pCBB31 using plsC-cat-F and plsC-cat-R primers) by recombinant PCR with overlapping sequences contained within the plsC-C&#x00394;7-R1 and plsC-cat-F primer pair, and the plsC-F2 and plsC-cat-R primer pair. The resulting fragment was used to transform <italic>B. subtilis </italic>strain 168 with selection for chloramphenicol resistance.</p></sec><sec><title>Construction of an IPTG-dependent mutant of <italic>B. subtilis plsX</italic></title><p>The <italic>plsX </italic>gene is located in the fatty acid biosynthesis operon composed of <italic>fapR</italic>, <italic>plsX</italic>, <italic>fabD</italic>, <italic>fabG</italic>, and <italic>acpA</italic>. To generate cells in which <italic>plsX </italic>expression was under the control of the IPTG-inducible Pspac promoter, we initially integrated Pspac-<italic>plsX </italic>into the <italic>aprE </italic>locus of the bacterial chromosome. The <italic>plsX </italic>gene was amplified by PCR using the pAP-plsX-F and pAP-plsX-R primers, and inserted between the Pspac promoter and the kanamycin-resistance gene (<italic>kan</italic>) on pAPNCK, that contains sequences upstream and downstream of <italic>aprE</italic>, flanking Pspac and <italic>kan</italic>. Plasmid pAPNCK was created by replacing the <italic>Hind</italic>III fragment (containing the spectinomycin-resistance gene) of pAPNC213 [<xref ref-type="bibr" rid="B17">17</xref>] with the <italic>Hind</italic>III fragment (containing the <italic>kan </italic>gene) of pDG780 [<xref ref-type="bibr" rid="B33">33</xref>]. The resulting plasmid was transformed into <italic>B. subtilis </italic>cells and selection of a double crossover using kanamycin resistance yielded strain MY110 (&#x00394;<italic>aprE</italic>::Pspac-<italic>plsX-kan</italic>). Next, the native <italic>plsX </italic>gene was replaced with the <italic>cat </italic>gene, without the promoter and terminator sequences, to ensure the correct expression of downstream essential genes. To achieve this, upstream and downstream regions of <italic>plsX </italic>were amplified using the plsX-F1and plsX-R1 primer pair, and the plsX-F2 and plsX-R2 primer pair, respectively. Fragments were ligated to the 5' and 3' ends of the <italic>cat </italic>gene (amplified from pCBB31 using primers cat-F-p and cat-R-t) by recombinant PCR using overlapping sequences in the plsX-R1 and cat-F-p primer pair, and the cat-R-t and plsX-F2 primer pair. The resulting fragment was used to transform strain MY110, and chloramphenicol-resistant transformants were selected to generate strain MY111 (&#x00394;<italic>aprE</italic>:: Pspac-<italic>plsX-kan </italic>&#x00394;<italic>plsX:</italic>:<italic>cat</italic>-p-t).</p></sec><sec><title>Analysis of phospholipid composition</title><p>Cells of <italic>B. subtilis </italic>strains 168, <italic>yneS-ts </italic>(MY103), and <italic>plsC</italic>-<italic>ts </italic>(MY112) were cultured in LB medium at 30&#x000b0;C until an OD<sub>600 </sub>of 0.4 was attained, and the temperature was then shifted to 42&#x000b0;C. Cells were pulse-labeled with <sup>32 </sup>[Pi] (50 &#x003bc;Ci/ml, Amersham Biosciences) for 5 min after 1 h of cultivation at 42&#x000b0;C. Incorporation of the label was terminated by the addition of 0.8 ml of culture to 3.0 ml of chloroform:methanol (1:2, v/v). Lipids were extracted using the method of Bligh and Dyer [<xref ref-type="bibr" rid="B20">20</xref>]. The phospholipids produced were examined by two-dimensional thin-layer chromatography on Silica Gel 60 plates (Merck) developed with chloroform:methanol:water (65:25:4) in the first dimension and chloroform:methanol:acetic acid (65:25:10) in the second dimension [<xref ref-type="bibr" rid="B5">5</xref>]. The incorporation of label into lysophosphatidic acid and other lipids was determined and quantitated using the BAS2500 image analyzer (Fuji).</p><p>Pspac-<italic>plsX </italic>(MY111) cells were cultured in LB medium containing 50 &#x003bc;M IPTG at 37&#x000b0;C until an OD<sub>600 </sub>value of 0.4 was attained. Cells were harvested, washed twice with LB medium, and suspended in 5 mL LB medium with or without 1 mM IPTG at final densities (OD<sub>600 </sub>values) of 0.06 or 0.1, respectively. Next, cells were pulse-labeled with <sup>32 </sup>[Pi] (50 &#x003bc;Ci/ml) for 5 min after 1 h of cultivation at 37&#x000b0;C. Lipid extraction and analysis were performed as described above.</p></sec><sec><title>Gene disruption in <italic>E. coli</italic></title><p>Deletions of the <italic>plsB</italic>, <italic>plsX</italic>, and <italic>ygiH </italic>genes were achieved using a one-step chromosomal gene inactivation method involving the phage &#x003bb; Red recombination system, as developed by Datsenko and Wanner [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. The <italic>E. coli </italic>strain, BW25113, was used. The primers used for target gene disruptions are listed in Table S4 [see Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>]. The 5' end of each primer contained 60&#x02013;70 bp of sequences upstream or downstream of the target gene, while the 3' end contained specific 20-nucleotide sequences from the template, pKD13. The primer pairs plsBdelup and plsBdeldown, plsXdelup and plsXdeldown, and ygiHdelup and ygiHdeldown, were used to generate &#x00394;<italic>plsB</italic>::<italic>kan </italic>(in strain MEC001), &#x00394;<italic>plsX</italic>::<italic>kan </italic>(in strain MEC002), and &#x00394;<italic>ygiH</italic>::<italic>kan </italic>(in strain MEC003) mutations, respectively. Because <italic>E. coli plsB </italic>was essential for growth, inactivation of <italic>plsB </italic>was performed in the presence of a plasmid harboring the gene (pSTV28<italic>plsB-p</italic>). Deletion mutations were confirmed using colony PCR with a <italic>kan</italic>-specific primer (k1 or k2) [<xref ref-type="bibr" rid="B22">22</xref>] and the locus-specific primers listed in Table S4 [see Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>]. The deletion mutations, &#x00394;<italic>plsX</italic>::<italic>kan </italic>and &#x00394;<italic>ygiH</italic>::<italic>kan</italic>, were transferred into prototrophic strain W3110 by P1<italic>vir </italic>transduction to obtain strains MEC005 and MEC006, respectively. The <italic>kan </italic>cassettes in strains MEC005 and MEC006 were removed with FLP recombinase, expressed by plasmid pCP20, as described previously [<xref ref-type="bibr" rid="B22">22</xref>], to obtain strains MEC102 and MEC103, respectively.</p></sec><sec><title>Construction of <italic>E. coli </italic>strains harboring IAA-inducible genes</title><p>To introduce <italic>plsB</italic>,<italic>plsX </italic>and <italic>ygiH </italic>genes, under the control of IAA-inducible <italic>trp </italic>promoters, into the <italic>E. coli </italic>chromosome, cloned gene fragments in pMC1403-based plasmids were transferred into the &#x003bb;RZ5 phage by <italic>recA</italic>-mediated homologous recombination as previously described [<xref ref-type="bibr" rid="B35">35</xref>]. The technique involves double crossovers between common upstream ampicillin-resistance genes and downstream <italic>lac </italic>operon sequences. The resulting &#x003bb;Pw-<italic>plsB</italic>, &#x003bb;Pw-<italic>plsX</italic>, and &#x003bb;Pw-<italic>ygiH </italic>phages were lysogenized into the W3110 chromosome, to obtain strains MEC199, MEC308, and MEC309, respectively. The &#x00394;<italic>plsB</italic>::<italic>kan </italic>mutation was transferred into strain MEC199 by P1<italic>vir </italic>transduction, and the <italic>kan </italic>cassette was then removed with FLP recombinase, expressed from plasmid pCP20, to obtain strain MEC201. The &#x003bb;Pw-<italic>plsX </italic>and &#x003bb;Pw-<italic>ygiH </italic>phages were also lysogenized into the strain MEC102 chromosome, to generate strains MEC303 and MEC304, respectively. The &#x00394;<italic>ygiH</italic>::<italic>kan </italic>mutation was then transferred into strains MEC303 and MEC304 by P1<italic>vir </italic>transduction.</p></sec></sec><sec><title>Abbreviations</title><p>G3P, Glycerol-3-phosphate; 1-acyl-G3P, 1-acyl-glycerol-phosphate; PA, phosphatidic acid; PG, phosphatidylglycerol; PE, phosphatidylethanolamine; CL, cardiolipin; IAA, 3&#x003b2;-indoleacrylic acid.</p></sec><sec><title>Authors' contributions</title><p>All experimental work was carried out by MY under the supervision of TO and NO. TO provided the <italic>E. coli </italic>transduction system. MY and TO wrote the draft manuscript. NO finalized the analysis and completed the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><italic>B. subtilis </italic>strains used in this study, and their genotypes. List of <italic>B. subtilis </italic>strains used in this study.</p></caption><media xlink:href="1471-2180-7-69-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><italic>E. coli </italic>strains used in this study, and their genotypes. List of <italic>E. coli </italic>strains used in this study.</p></caption><media xlink:href="1471-2180-7-69-S2.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p>Plasmids used in this study. List of plasmids used in this study.</p></caption><media xlink:href="1471-2180-7-69-S3.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional file 4</title><p>Oligonucleotides used in this study. List of oligonucleotides used in this study.</p></caption><media xlink:href="1471-2180-7-69-S4.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We are grateful to Fujio Kawamura (Rikkyo University) for providing plasmid pCH11. TL84 (ME8400) was supplied by the National BioResource Project for <italic>E. coli </italic>(National Institute of Genetics). We thank Toshifumi Inada (Nagoya University) for helpful discussions. This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for JSPS Research Fellowships for Young Scientists to MY.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cronan</surname><given-names>JEJ</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Neidhardt FC</surname></name></person-group><article-title>Biosynthesis of membrane lipids</article-title><source>Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology</source><year>1987</year><publisher-name>American Society for Microbiology</publisher-name><fpage>474</fpage><lpage>497</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Chateau</surname><given-names>M</given-names></name><name><surname>Bjorck</surname><given-names>L</given-names></name></person-group><article-title>Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>12147</fpage><lpage>12151</lpage><pub-id pub-id-type="pmid">8163519</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>TJ</given-names></name><name><surname>Ludtke</surname><given-names>DN</given-names></name><name><surname>Bell</surname><given-names>RM</given-names></name></person-group><article-title>sn-Glycerol-3-phosphate auxotrophy of <italic>plsB </italic>strains of <italic>Escherichia coli</italic>: evidence that a second mutation, <italic>plsX</italic>, is required</article-title><source>J Bacteriol</source><year>1984</year><volume>160</volume><fpage>711</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">6094487</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>RJ</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>A conserved histidine is essential for glycerolipid acyltransferase catalysis</article-title><source>J Bacteriol</source><year>1998</year><volume>180</volume><fpage>1425</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">9515909</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J</given-names></name></person-group><article-title>Characterization of <italic>Escherichia coli </italic>cells deficient in 1-acyl-sn-glycerol-3- phosphate acyltransferase activity</article-title><source>J Biol Chem</source><year>1990</year><volume>265</volume><fpage>17215</fpage><lpage>17221</lpage><pub-id pub-id-type="pmid">2211622</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>RJ</given-names></name><name><surname>Goldfine</surname><given-names>H</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>A gene (<italic>plsD</italic>) from <italic>Clostridium butyricum </italic>that functionally substitutes for the sn-glycerol-3-phosphate acyltransferase gene (<italic>plsB</italic>) of <italic>Escherichia coli</italic></article-title><source>J Bacteriol</source><year>1997</year><volume>179</volume><fpage>7257</fpage><lpage>7263</lpage><pub-id pub-id-type="pmid">9393688</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>TK</given-names></name><name><surname>Cronan</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group><article-title>Acylation of sn-glycerol 3-phosphate in <italic>Escherichia coli</italic>. Study of reaction with native palmitoyl-acyl carrier protein</article-title><source>J Biol Chem</source><year>1975</year><volume>250</volume><fpage>8422</fpage><lpage>8427</lpage><pub-id pub-id-type="pmid">1104604</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>YJ</given-names></name><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Grimes</surname><given-names>KD</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>RE</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>Acyl-phosphates initiate membrane phospholipid synthesis in Gram-positive pathogens</article-title><source>Mol Cell</source><year>2006</year><volume>23</volume><fpage>765</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">16949372</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2006.06.030</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>YJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Grimes</surname><given-names>KD</given-names></name><name><surname>Lee</surname><given-names>RE</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>Topology and Active Site of PlsY: THE BACTERIAL ACYLPHOSPHATE:GLYCEROL- 3-PHOSPHATE ACYLTRANSFERASE</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>11339</fpage><lpage>11346</lpage><pub-id pub-id-type="pmid">17308305</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M700374200</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Ehrlich</surname><given-names>SD</given-names></name><name><surname>Albertini</surname><given-names>A</given-names></name><name><surname>Amati</surname><given-names>G</given-names></name><name><surname>Andersen</surname><given-names>KK</given-names></name><name><surname>Arnaud</surname><given-names>M</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Ashikaga</surname><given-names>S</given-names></name><name><surname>Aymerich</surname><given-names>S</given-names></name><name><surname>Bessieres</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Essential <italic>Bacillus subtilis </italic>genes</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>4678</fpage><lpage>4683</lpage><pub-id pub-id-type="pmid">12682299</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0730515100</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schujman</surname><given-names>GE</given-names></name><name><surname>Paoletti</surname><given-names>L</given-names></name><name><surname>Grossman</surname><given-names>AD</given-names></name><name><surname>de Mendoza</surname><given-names>D</given-names></name></person-group><article-title>FapR, a bacterial transcription factor involved in global regulation of membrane lipid biosynthesis</article-title><source>Dev Cell</source><year>2003</year><volume>4</volume><fpage>663</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">12737802</pub-id><pub-id pub-id-type="doi">10.1016/S1534-5807(03)00123-0</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seki</surname><given-names>T</given-names></name><name><surname>Miyachi</surname><given-names>H</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>F</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name></person-group><article-title>An improved methd of prophage transformation in <italic>Bacillus subtilis </italic></article-title><source>J Gen Appl Microbiol</source><year>1986</year><volume>32</volume><fpage>73</fpage><lpage>79</lpage></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Haga</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group><article-title>Analysis of the <italic>Bacillus subtilis spoIIIJ </italic>gene and its Paralogue gene, <italic>yqjG</italic></article-title><source>J Bacteriol</source><year>2002</year><volume>184</volume><fpage>1998</fpage><lpage>2004</lpage><pub-id pub-id-type="pmid">11889108</pub-id><pub-id pub-id-type="doi">10.1128/JB.184.7.1998-2004.2002</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beijer</surname><given-names>L</given-names></name><name><surname>Nilsson</surname><given-names>RP</given-names></name><name><surname>Holmberg</surname><given-names>C</given-names></name><name><surname>Rutberg</surname><given-names>L</given-names></name></person-group><article-title>The <italic>glpP </italic>and <italic>glpF </italic>genes of the glycerol regulon in <italic>Bacillus subtilis</italic></article-title><source>J Gen Microbiol</source><year>1993</year><volume>139</volume><fpage>349</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">8436953</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glatz</surname><given-names>E</given-names></name><name><surname>Persson</surname><given-names>M</given-names></name><name><surname>Rutberg</surname><given-names>B</given-names></name></person-group><article-title>Antiterminator protein GlpP of <italic>Bacillus subtilis </italic>binds to <italic>glpD </italic>leader mRNA</article-title><source>Microbiology</source><year>1998</year><volume>144</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">9493382</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>OH</surname><given-names>YK</given-names></name><name><surname>Freese</surname><given-names>EB</given-names></name><name><surname>Freese</surname><given-names>E</given-names></name></person-group><article-title>Abnormal septation and inhibition of sporulation by accumulation of L- -glycerophosphate in <italic>Bacillus subtilis </italic>mutants</article-title><source>J Bacteriol</source><year>1973</year><volume>113</volume><fpage>1034</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">4632310</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>T</given-names></name><name><surname>Loh</surname><given-names>PC</given-names></name><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Moriya</surname><given-names>S</given-names></name><name><surname>Ogasawara</surname><given-names>N</given-names></name></person-group><article-title>Six GTP-binding proteins of the Era/Obg family are essential for cell growth in <italic>Bacillus subtilis </italic></article-title><source>Microbiology</source><year>2002</year><volume>148</volume><fpage>3539</fpage><lpage>3552</lpage><pub-id pub-id-type="pmid">12427945</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freese</surname><given-names>EB</given-names></name><name><surname>Oh</surname><given-names>YK</given-names></name></person-group><article-title>Adenosine 5'-triphosphate release and membrane collapse in glycerol-requiring mutants of <italic>Bacillus subtilis </italic></article-title><source>J Bacteriol</source><year>1974</year><volume>120</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">4371436</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>YK</given-names></name><name><surname>Freese</surname><given-names>EB</given-names></name><name><surname>Freese</surname><given-names>E</given-names></name></person-group><article-title>Abnormal septation and inhibition of sporulation by accumulation of L- -glycerophosphate in <italic>Bacillus subtilis </italic>mutants</article-title><source>J Bacteriol</source><year>1973</year><volume>113</volume><fpage>1034</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">4632310</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bligh</surname><given-names>EG</given-names></name><name><surname>Dyer</surname><given-names>WJ</given-names></name></person-group><article-title>A rapid method of total lipid extraction and purification</article-title><source>Can J Biochem Physiol</source><year>1959</year><volume>37</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">13671378</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname><given-names>SY</given-names></name><name><surname>Scholle</surname><given-names>MD</given-names></name><name><surname>Campbell</surname><given-names>JW</given-names></name><name><surname>Balazsi</surname><given-names>G</given-names></name><name><surname>Ravasz</surname><given-names>E</given-names></name><name><surname>Daugherty</surname><given-names>MD</given-names></name><name><surname>Somera</surname><given-names>AL</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name><name><surname>Anderson</surname><given-names>I</given-names></name><name><surname>Gelfand</surname><given-names>MS</given-names></name><etal></etal></person-group><article-title>Experimental determination and system level analysis of essential genes in <italic>Escherichia coli </italic>MG1655</article-title><source>J Bacteriol</source><year>2003</year><volume>185</volume><fpage>5673</fpage><lpage>5684</lpage><pub-id pub-id-type="pmid">13129938</pub-id><pub-id pub-id-type="doi">10.1128/JB.185.19.5673-5684.2003</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli </italic>K-12 using PCR products</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="pmid">10829079</pub-id><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>RJ</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>A missense mutation accounts for the defect in the glycerol-3-phosphate acyltransferase expressed in the <italic>plsB26 </italic>mutant</article-title><source>J Bacteriol</source><year>1999</year><volume>181</volume><fpage>1944</fpage><lpage>1946</lpage><pub-id pub-id-type="pmid">10074094</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Cronan</surname><given-names>JEJ</given-names></name></person-group><article-title>Inhibition of fatty acid synthesis in <italic>Escherichia coli </italic>in the absence of phospholipid synthesis and release of inhibition by thioesterase action</article-title><source>J Bacteriol</source><year>1994</year><volume>176</volume><fpage>2814</fpage><lpage>2821</lpage><pub-id pub-id-type="pmid">7910602</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Cronan</surname><given-names>JEJ</given-names></name></person-group><article-title><italic>Escherichia coli </italic>thioesterase I, molecular cloning and sequencing of the structural gene and identification as a periplasmic enzyme</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>9238</fpage><lpage>9245</lpage><pub-id pub-id-type="pmid">8098033</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>MA</given-names></name><name><surname>Alwood</surname><given-names>A</given-names></name><name><surname>Thaipisuttikul</surname><given-names>I</given-names></name><name><surname>Spencer</surname><given-names>D</given-names></name><name><surname>Haugen</surname><given-names>E</given-names></name><name><surname>Ernst</surname><given-names>S</given-names></name><name><surname>Will</surname><given-names>O</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Raymond</surname><given-names>C</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Comprehensive transposon mutant library of <italic>Pseudomonas aeruginosa </italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>14339</fpage><lpage>14344</lpage><pub-id pub-id-type="pmid">14617778</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2036282100</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>CO</given-names></name><name><surname>Jackowski</surname><given-names>S</given-names></name></person-group><article-title>Regulation of phospholipid synthesis in <italic>Escherichia coli</italic>. Composition of the acyl-acyl carrier protein pool <italic>in vivo</italic></article-title><source>J Biol Chem</source><year>1982</year><volume>257</volume><fpage>10759</fpage><lpage>10765</lpage><pub-id pub-id-type="pmid">6809756</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>RJ</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name></person-group><article-title>Regulation of malonyl-CoA metabolism by acyl-acyl carrier protein and beta-ketoacyl-acyl carrier protein synthases in <italic>Escherichia coli </italic></article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>15531</fpage><lpage>15538</lpage><pub-id pub-id-type="pmid">7797547</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.26.15531</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubnau</surname><given-names>D</given-names></name><name><surname>Davidoff-Abelson</surname><given-names>R</given-names></name></person-group><article-title>Fate of transforming DNA following uptake by competent <italic>Bacillus subtilis</italic>. I. Formation and properties of the donor-recipient complex</article-title><source>J Mol Biol</source><year>1971</year><volume>56</volume><fpage>209</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">4994568</pub-id><pub-id pub-id-type="doi">10.1016/0022-2836(71)90460-8</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casadaban</surname><given-names>MJ</given-names></name><name><surname>Chou</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>SN</given-names></name></person-group><article-title>In vitro gene fusions that join an enzymatically active &#x003b2;-galactosidase segment to amino-terminal fragments of exogenous proteins: <italic>Escherichia coli </italic>plasmid vectors for the detection and cloning of translational initiation signals</article-title><source>J Bacteriol</source><year>1980</year><volume>143</volume><fpage>971</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">6162838</pub-id></citation></ref><ref id="B31"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><source>Characterization of spoII genes of <italic>Bacillus subtilis</italic></source><year>1989</year><publisher-name>PhD Thesis Hiroshima University</publisher-name></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>LF</given-names></name><name><surname>Doi</surname><given-names>RH</given-names></name></person-group><article-title>Catabolite-resistant sporulation (<italic>crsA</italic>) mutations in the <italic>Bacillus subtilis </italic>RNA polymerase sigma 43 gene (<italic>rpoD</italic>) can suppress and be suppressed by mutations in <italic>spo0 </italic>genes</article-title><source>Proc Natl Acad Sci U S A</source><year>1985</year><volume>82</volume><fpage>8124</fpage><lpage>8128</lpage><pub-id pub-id-type="pmid">3934667</pub-id><pub-id pub-id-type="doi">10.1073/pnas.82.23.8124</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guerout-Fleury</surname><given-names>AM</given-names></name><name><surname>Shazand</surname><given-names>K</given-names></name><name><surname>Frandsen</surname><given-names>N</given-names></name><name><surname>Stragier</surname><given-names>P</given-names></name></person-group><article-title>Antibiotic-resistance cassettes for <italic>Bacillus subtilis </italic></article-title><source>Gene</source><year>1995</year><volume>167</volume><fpage>335</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">8566804</pub-id><pub-id pub-id-type="doi">10.1016/0378-1119(95)00652-4</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>T</given-names></name><name><surname>Aiba</surname><given-names>H</given-names></name><name><surname>Masuda</surname><given-names>Y</given-names></name><name><surname>Kanaya</surname><given-names>S</given-names></name><name><surname>Sugiura</surname><given-names>M</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name></person-group><article-title>Transcriptome analysis of all two-component regulatory system mutants of <italic>Escherichia coli </italic>K-12</article-title><source>Mol Microbiol</source><year>2002</year><volume>46</volume><fpage>281</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">12366850</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03170.x</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>Multiple control of <italic>Escherichia coli </italic>lysyl-tRNA synthetase expression involves a transcriptional repressor and a translational enhancer element</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>302</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">7678344</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.1.302</pub-id></citation></ref></ref-list></back></article> 